4 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $4M | -$8M | 84.2% | -219.4% | -$6M | — | $5M |
| 2024 | $3M | -$8M | 86.5% | -266.5% | -$6M | — | $4M |
| 2023 | $2M | -$15M | 87.7% | -270.9% | -$7M | — | $78560 |
| 2022 | $3M | -$5M | 88.9% | -125.6% | -$2M | $228342 | $253699 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $2M | -$2M | 86.4% | -108.3% | — | — | $7M |
| Dec '25 | $968127 | -$2M | 85.4% | -177.3% | -$2M | — | $5M |
| Sep '25 | $811414 | -$2M | 83.3% | -258.8% | -$1M | — | $4M |
| Jun '25 | $894086 | -$2M | 83.6% | -192.1% | -$1M | — | $6M |
| Mar '25 | $895655 | -$2M | 84.4% | -256.2% | -$2M | — | $2M |
| Dec '24 | $761165 | -$1M | 86.2% | -192.7% | -$2M | — | $4M |
| Sep '24 | $666625 | -$2M | 85.4% | -247.7% | -$1M | — | $260885 |
| Jun '24 | $611500 | -$3M | 88.0% | -360.9% | -$2M | — | $2M |
| Mar '24 | $646635 | -$2M | 88.4% | -283.3% | -$1M | — | $81752 |
| Dec '23 | $531459 | -$2M | 86.4% | -305.4% | -$3M | — | $78560 |
| Sep '23 | $477460 | -$9M | 85.9% | -633.0% | -$3M | — | $761249 |
| Jun '23 | $646021 | -$2M | 89.5% | -173.0% | -$629684 | — | $51440 |
| Mar '23 | $805110 | -$2M | 88.1% | -111.3% | -$630520 | — | — |
| Dec '22 | $613082 | -$13628 | 87.7% | -160.9% | -$204315 | $228342 | $253699 |
| Sep '22 | $618805 | -$2M | 89.1% | -194.4% | — | — | — |
| Jun '22 | $682581 | -$2M | 88.4% | -98.1% | — | — | — |
| Mar '22 | — | -$1M | — | — | — | — | — |
How the market has priced NRXS against its own fundamentals since 2023-08 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 3 years, Neuraxis, INC's revenue has grown 10.0% per year. These are computed facts, not advice.
As of FY2025, Neuraxis, INC reported — of total debt against $5M of cash; operating income covered interest expense -105.9×.
In FY2025, gross margin was 84.2%, operating margin -219.4%, and net margin -218.5%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.